Administración de Empresas
Fachbereich
![Foto de Administración de Empresas](/img/uploaded/F604C5D6976D4D722ACE810ACE624981.jpg)
![Foto de Karolinska Institute](/img/noimage_org.png)
Karolinska Institute
Estocolmo, SueciaPublikationen in Zusammenarbeit mit Forschern von Karolinska Institute (4)
2022
-
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 8, Núm. 1, pp. 31-38
-
Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
Upsala Journal of Medical Sciences, Vol. 127
2019
2016
-
Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
Clinical Cardiology, Vol. 39, Núm. 6, pp. 313-320